Vinayak Muralidhar

1.5k total citations
52 papers, 509 citations indexed

About

Vinayak Muralidhar is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Vinayak Muralidhar has authored 52 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 10 papers in Surgery. Recurrent topics in Vinayak Muralidhar's work include Prostate Cancer Diagnosis and Treatment (35 papers), Prostate Cancer Treatment and Research (29 papers) and Advanced Radiotherapy Techniques (8 papers). Vinayak Muralidhar is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (35 papers), Prostate Cancer Treatment and Research (29 papers) and Advanced Radiotherapy Techniques (8 papers). Vinayak Muralidhar collaborates with scholars based in United States and United Kingdom. Vinayak Muralidhar's co-authors include Paul L. Nguyen, Brandon A. Mahal, Peter F. Orio, Neil E. Martin, Kent W. Mouw, David D. Yang, Martin T. King, Felix Y. Feng, Clair J. Beard and Danielle N. Margalit and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Vinayak Muralidhar

49 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vinayak Muralidhar United States 14 269 171 126 59 58 52 509
Anne‐Valérie Guizard France 16 160 0.6× 259 1.5× 91 0.7× 8 0.1× 65 1.1× 37 635
Richard Li United States 12 151 0.6× 100 0.6× 115 0.9× 76 1.3× 128 2.2× 36 425
Nathan Y. Yu United States 11 250 0.9× 99 0.6× 87 0.7× 212 3.6× 133 2.3× 71 453
Arnaud Belard United States 8 270 1.0× 54 0.3× 84 0.7× 223 3.8× 158 2.7× 14 521
Eleonora Ferrara Italy 7 96 0.4× 244 1.4× 97 0.8× 18 0.3× 74 1.3× 15 383
B. Lapôtre‐Ledoux France 15 128 0.5× 217 1.3× 106 0.8× 3 0.1× 19 0.3× 30 532
Andrew T. Wong United States 14 259 1.0× 161 0.9× 141 1.1× 45 0.8× 59 1.0× 30 439
Eric Gutierrez Canada 14 176 0.7× 106 0.6× 134 1.1× 130 2.2× 159 2.7× 38 481
L. Henry Garland United States 12 311 1.2× 116 0.7× 78 0.6× 14 0.2× 82 1.4× 47 664
Joanna Harton United States 6 119 0.4× 70 0.4× 44 0.3× 77 1.3× 47 0.8× 20 277

Countries citing papers authored by Vinayak Muralidhar

Since Specialization
Citations

This map shows the geographic impact of Vinayak Muralidhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinayak Muralidhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinayak Muralidhar more than expected).

Fields of papers citing papers by Vinayak Muralidhar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinayak Muralidhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinayak Muralidhar. The network helps show where Vinayak Muralidhar may publish in the future.

Co-authorship network of co-authors of Vinayak Muralidhar

This figure shows the co-authorship network connecting the top 25 collaborators of Vinayak Muralidhar. A scholar is included among the top collaborators of Vinayak Muralidhar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinayak Muralidhar. Vinayak Muralidhar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dee, Edward Christopher, Kenrick Ng, Gloryanne Aidoo-Micah, et al.. (2024). Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards. Nature Reviews Urology. 22(4). 223–234. 4 indexed citations
2.
Royce, Trevor J., et al.. (2021). US Primary Care vs Specialty Care Trainee Positions and Physician Incomes: Trends From 2001 to 2019. Journal of Graduate Medical Education. 13(3). 385–389. 3 indexed citations
3.
Mossanen, Matthew, Filipe L.F. Carvalho, Vinayak Muralidhar, et al.. (2021). Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy. European Urology. 81(5). 466–473. 13 indexed citations
4.
Dee, Edward Christopher, Matthew Mossanen, Brandon A. Mahal, et al.. (2021). Clinical characterization of radiation-associated muscle-invasive bladder cancer. Urology. 154. 208–214. 4 indexed citations
5.
Butler, Santino, Brandon A. Mahal, Vinayak Muralidhar, et al.. (2020). Short‐term mortality risks among patients with oropharynx cancer by human papillomavirus status. Cancer. 126(7). 1424–1433. 21 indexed citations
6.
Chipidza, Fallon, Mohammed Alshalalfa, Brandon A. Mahal, et al.. (2020). Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer. Clinical Genitourinary Cancer. 19(3). 246–254.e5. 9 indexed citations
7.
Lee, Grace, Daniel W. Kim, Vinayak Muralidhar, et al.. (2020). Chemoradiation-related lymphopenia and its association with survival in patients with anal cancer.. Journal of Clinical Oncology. 38(4_suppl). 3–3. 1 indexed citations
8.
King, Martin T., David D. Yang, Vinayak Muralidhar, et al.. (2019). A comparative analysis of overall survival between high-dose-rate and low-dose-rate brachytherapy boosts for unfavorable-risk prostate cancer. Brachytherapy. 18(2). 186–191. 18 indexed citations
9.
Vastola, M., David D. Yang, Brandon A. Mahal, et al.. (2018). Laboratory eligibility criteria as potential barriers to participation by black men in prostate cancer clinical trials.. Journal of Clinical Oncology. 36(6_suppl). 73–73. 1 indexed citations
10.
Yang, David D., Brandon A. Mahal, Vinayak Muralidhar, et al.. (2017). Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3 + 4 Favorable Intermediate-risk Prostate Cancer. European Urology Focus. 5(1). 69–76. 41 indexed citations
11.
Yang, David D., Vinayak Muralidhar, Brandon A. Mahal, et al.. (2017). Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy. Urologic Oncology Seminars and Original Investigations. 35(9). 542.e25–542.e32. 3 indexed citations
12.
Yang, David D., Brandon A. Mahal, Vinayak Muralidhar, et al.. (2017). Receipt of definitive therapy in elderly patients with unfavorable‐risk prostate cancer. Cancer. 123(24). 4832–4840. 13 indexed citations
13.
Yang, David D., Vinayak Muralidhar, Paul L. Nguyen, et al.. (2017). Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(4). 904–911. 6 indexed citations
14.
Yang, David D., Vinayak Muralidhar, Brandon A. Mahal, et al.. (2017). Lack of Apparent Survival Benefit With Use of Androgen Deprivation Therapy in Patients With High-risk Prostate Cancer Receiving Combined External Beam Radiation Therapy and Brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 100(1). 53–58. 8 indexed citations
15.
Sridharan, Vishwajith, Vinayak Muralidhar, Danielle N. Margalit, et al.. (2016). Merkel Cell Carcinoma: A Population Analysis on Survival. Journal of the National Comprehensive Cancer Network. 14(10). 1247–1257. 55 indexed citations
16.
Muralidhar, Vinayak, Ryan David Nipp, David P. Ryan, et al.. (2016). Association Between Very Small Tumor Size and Increased Cancer-Specific Mortality in Node-Positive Colon Cancer. Diseases of the Colon & Rectum. 59(3). 187–193. 21 indexed citations
17.
Muralidhar, Vinayak, Brandon A. Mahal, & Paul L. Nguyen. (2015). Conditional Cancer-Specific Survival in Prostate Cancer Patients With Very-High-Risk Features: Implications for Long-Term Prognosis. International Journal of Radiation Oncology*Biology*Physics. 93(3). E204–E204. 1 indexed citations
18.
Muralidhar, Vinayak, Brandon A. Mahal, David R. Ziehr, et al.. (2015). Shifting brachytherapy monotherapy case mix toward intermediate-risk prostate cancer. Brachytherapy. 14(4). 511–516. 4 indexed citations
19.
Muralidhar, Vinayak, Meredith M. Regan, Lillian Werner, et al.. (2015). Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center. Clinical Genitourinary Cancer. 14(4). e299–e305. 8 indexed citations
20.
Muralidhar, Vinayak, Brandon A. Mahal, & Paul L. Nguyen. (2015). Conditional cancer-specific mortality in T4, N1, or M1 prostate cancer: implications for long-term prognosis. Radiation Oncology. 10(1). 155–155. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne‐Valérie Guizard Breakdown of academic impact, for papers by Richard Li Breakdown of academic impact, for papers by Nathan Y. Yu Breakdown of academic impact, for papers by Arnaud Belard Breakdown of academic impact, for papers by Eleonora Ferrara Breakdown of academic impact, for papers by B. Lapôtre‐Ledoux Breakdown of academic impact, for papers by Andrew T. Wong Breakdown of academic impact, for papers by Eric Gutierrez Breakdown of academic impact, for papers by L. Henry Garland Breakdown of academic impact, for papers by Joanna Harton
Rankless by CCL
2026